{"data_7KNN-plus":{"struct_ref_pdbmlplus":{"id":["SIFTS_UNP_1"],"db_name":["SIFTS_UNP"],"entity_id":["1"],"pdbx_db_accession":["P69747"]},"struct_ref_seq_pdbmlplus":{"align_id":["SIFTS_UNP_SEQ_1"],"db_align_beg":[50],"db_align_end":[65],"pdbx_auth_seq_align_beg":["1"],"pdbx_auth_seq_align_end":["16"],"pdbx_db_accession":["P69747"],"pdbx_strand_id":["A"],"ref_id":["SIFTS_UNP_1"],"seq_align_beg":[1],"seq_align_end":[16]},"struct_site_pdbmlplus":{"id":["SWS_FT_FI1","SWS_FT_FI2","SWS_FT_FI3"],"info_type":["Swiss-Prot","Swiss-Prot","Swiss-Prot"],"info_subtype":["Region","Region","Modified residue"],"details":["{\"description\":\"Ser-Xaa-Pro motif, crucial for potent interaction with nAChR\",\"evidences\":[{\"source\":\"UniProtKB\",\"id\":\"P56636\",\"evidenceCode\":\"ECO:0000250\"}]}","{\"description\":\"Key region for inhibition of alpha-9-alpha-10/CHRNA9-CHRNA10 nAChR\",\"evidences\":[{\"source\":\"PubMed\",\"id\":\"19447885\",\"evidenceCode\":\"ECO:0000305\"}]}","{\"description\":\"4-hydroxyproline\",\"evidences\":[{\"source\":\"PubMed\",\"id\":\"15170751\",\"evidenceCode\":\"ECO:0000269\"}]}"],"pdbx_num_residues":[2,2,1]},"link_entry_pdbjplus":{"db_name":["bmrb","efsite","promode"],"db_accession":[["30811"],["7knn_1-A","7knn_10-A","7knn_11-A","7knn_12-A","7knn_13-A","7knn_14-A","7knn_15-A","7knn_16-A","7knn_17-A","7knn_18-A","7knn_19-A","7knn_2-A","7knn_20-A","7knn_3-A","7knn_4-A","7knn_5-A","7knn_6-A","7knn_7-A","7knn_8-A","7knn_9-A"],["7knn"]]},"link_asym_pdbjplus":{"asym_id":["A"],"pdb_strand_id":["A"],"entity_id":["1"]},"align_pdbjplus":{"entity_id":["1"],"asym_id":["A"],"align_id":[0],"beg_label_seq_id":[7],"end_label_seq_id":[12],"db_align_beg":[52],"db_align_end":[57],"db_name":["UniProt"],"pdbx_db_accession":["P69747"]}}}